Renal osteodystrophy: A pediatric perspective, 2005

Growth Hormone and IGF Research

Volumn 15, Issue SUPPL., 2005, Pages 42-47

  Langman, Craig B ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Calcium; Growth disorder; Growth hormone; Phosphorus; Secondary hyperparathyroidism

Indexed keywords

CALCIMIMETIC AGENT; CALCITRIOL; GROWTH HORMONE; VITAMIN D DERIVATIVE;

ALGORITHM; ARTHRITIS; ARTICLE; BONE DEVELOPMENT; BONE REMODELING; CALCIFICATION; CHILD; CHILD CARE; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG MECHANISM; DRUG RESPONSE; FOLLOW UP; GROWTH DISORDER; GROWTH PLATE; HOMEOSTASIS; HUMAN; HYPERPARATHYROIDISM; KIDNEY TRANSPLANTATION; LONG TERM CARE; OSTEOPOROSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; VITAMIN SUPPLEMENTATION;

EID: 22744452672     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2005.06.009     Document Type: Article

References (33)

1. R.J. Hogg S. Furth K.V. Lemley National Kidney Foundation Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: Evaluation, classification, and stratification Pediatrics 111 2003 1416-1421
2. E. Seeman Clinical review 137: Sexual dimorphism in skeletal size, density, and strength J. Clin. Endocrinol. Metab. 86 2001 4576-4584
3. H.M. Frost A 2003 update of bone physiology and Wolff's Law for clinicians Angle Orthod. 74 2004 3-15
4. R. Nissel I. Brazda R. Feneberg et al. Effect of renal transplantation in childhood on longitudinal growth and adult height Kidney Int. 66 2004 792-800
5. L.S. Ibels J.H. Stewart J.F. Mahony F.C. Neale A.G. Sheil Occlusive arterial disease in uraemic and haemodialysis patients and renal transplant recipients. A study of the incidence of arterial disease and of the prevalence of risk factors implicated in the pathogenesis of arteriosclerosis Q. J. Med. 46 1977 197-214
6. I.B. Salusky W.G. Goodman Cardiovascular calcification in end-stage renal disease Nephrol. Dial. Transplant. 17 2002 336-339
7. C.B. Langman New developments in calcium and vitamin D metabolism Curr. Opin. Pediatr. 12 2000 135-139
8. A.A. Portale B.E. Booth B.P. Halloran R.C. Morris Jr. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency J. Clin. Invest. 73 1984 1580-1589
9. I. Hendrix P.H. Anderson J.L. Omdahl B.K. May H.A. Morris Response of the 5′-flanking region of the human 25-hydroxyvitamin D 1{alpha}-hydroxylase gene to physiological stimuli using a transgenic mouse model J. Mol. Endocrinol. 34 2005 237-245
10. S. Yumita M. Suzuki T. Akiba T. Akizawa Y. Seino K. Kurokawa Levels of serum 1,25(OH)2D in patients with pre-dialysis chronic renal failure Tohoku J. Exp. Med. 180 1996 45-56
11. A.S. Dusso Vitamin D receptor: Mechanisms for vitamin D resistance in renal failure Kidney Int. 85 Suppl. 2003 S6-S9
12. M. Martin-Salvago J.L. Villar-Rodriguez A. Palma-Alvarez A. Beato-Moreno H. Galera-Davidson Decreased expression of calcium receptor in parathyroid tissue in patients with hyperparathyroidism secondary to chronic renal failure Endocr. Pathol. 14 2003 61-70
13. S. Bas E. Aguilera-Tejero A. Bas J.C. Estepa I. Lopez J.A. Madueno J.M. Rodriguez The influence of the progression of secondary hyperparathyroidism on the set point of the parathyroid hormone-calcium curve J. Endocrinol. 184 2005 241-247
14. L. Cuppari A.B. Carvalho R.R. Lobao et al. Parathyroid hormone changes during phosphorus load in patients with chronic renal insufficiency with low serum parathyroid hormone or adynamic bone disease Clin. Nephrol. 56 2001 35-43
15. I.K. van Vonderen H.S. Kooistra M.E. Peeters A. Rijnberk T.S. van den Ingh Parathyroid hormone immunohistochemistry in dogs with primary and secondary hyperparathyroidism: The question of adenoma and primary hyperplasia J. Comp. Pathol. 129 2003 61-69
16. R. Santamaria Y. Almaden A. Felsenfeld et al. Dynamics of PTH secretion in hemodialysis patients as determined by the intact and whole PTH assays Kidney Int. 64 2003 1867-1873
17. D.R. Powell F. Liu B.K. Baker R.L. Hintz A. Kale A. Suwanichkul S.K. Durham Effect of chronic renal failure and growth hormone therapy on the insulin-like growth factors and their binding proteins Pediatr. Nephrol. 14 2000 579-583
18. Y. Kasukawa N. Miyakoshi S. Mohan The anabolic effects of GH/IGF system on bone Curr. Pharm. Des. 10 2004 2577-2592
19. A.C. Hokken-Koelega P. Saenger M. Cappa N. Greggio International Workshop on Management of Puberty for Optimum Auxological Results. Unresolved problems concerning optimal therapy of puberty in children with chronic renal diseases J. Pediatr. Endocrinol. Metab. 14 Suppl. 2 2001 945-952
20. R.I. Gafni M. Weise D.T. Robrecht et al. Catch-up growth is associated with delayed senescence of the growth plate in rabbits Pediatr. Res. 50 2001 618-623
21. I.B. Salusky W.G. Goodman Adynamic renal osteodystrophy: Is there a problem? J. Am. Soc. Nephrol. 12 2001 1978-1985
22. G. Coen P. Ballanti A. Balducci et al. Serum osteoprotegerin and renal osteodystrophy Nephrol. Dial. Transplant. 17 2002 233-238
23. K.J. Martin K. Olgaard J.W. Coburn et al. Bone Turnover Work Group, Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy Am. J. Kidney Dis. 43 2004 558-565
24. E.A. Gonzalez A. Sachdeva D.A. Oliver K.J. Martin Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study Am. J. Nephrol. 24 2004 503-510
25. J.S. Finkelstein D.A. Schoenfeld Effects of gonadal suppression on the regulation of parathyroid hormone and 1,25-dihydroxyvitamin D secretion in women J. Clin. Endocrinol. Metab. 84 1999 2151-2156
26. J. Floege M. Ketteler Vascular calcification in patients with end-stage renal disease Nephrol. Dial. Transplant. 19 Suppl. 5 2004 V59-V66
27. D.S. Milliner A.R. Zinsmeister E. Lieberman B. Landing Soft tissue calcification in pediatric patients with end-stage renal disease Kidney Int. 38 1990 931-936
28. J. Cunningham New vitamin D analogues for osteodystrophy in chronic kidney disease Pediatr. Nephrol. 19 2004 705-708
29. M. Teng M. Wolf E. Lowrie N. Ofsthun J.M. Lazarus R. Thadhani Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy N. Engl. J. Med. 349 2003 446-456
30. K.J. Martin I. Akhtar E.A. Gonzalez Parathyroid hormone: New assays, new receptors Semin. Nephrol. 24 2004 3-9
31. Growth failure in children with renal diseases, A clinical trial in pediatric nephrology: Growth Failure in Renal Diseases (GFRD) Study, J. Pediatr. 116 (1990) S1-S62.
32. L.A. Greenbaum M. Del Rio F. Bamgbola F. Kaskel Rationale for growth hormone therapy in children with chronic kidney disease Adv. Chronic Kidney Dis. 11 2004 377-386
33. T.B. Drueke Calcimimetics versus vitamin D: What are their relative roles? Blood Purif. 22 2004 38-43